Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Helmut Prosch

Showing results (171-180 of 230) with videos related to

Pageof 23
Sort By:
Radiology|March 25, 2017
Lung-RADS Category 4X: Does It Improve Prediction of Malignancy in Subsolid Nodules?Kaman Chung, Colin Jacobs, Ernst T Scholten, et al.
European Journal of Radiology|July 18, 2016
Antisynthetase syndrome: Pulmonary computed tomography findings of adult patients with antibodies to aminoacyl-tRNA synthetasesYuko Waseda, Takeshi Johkoh, Ryoko Egashira, et al.
The Journal of Thoracic and Cardiovascular Surgery|April 15, 2018
Intraoperative extracorporeal membrane oxygenation and the possibility of postoperative prolongation improve survival in bilateral lung transplantationKonrad Hoetzenecker, Stefan Schwarz, Moritz Muckenhuber, et al.
Journal of Autoimmunity|August 8, 2025
FAPI PET/CT for tracking disease trajectory in myositis-related interstitial lung diseaseKastriot Kastrati, Svitlana Pochepnia, Oana C Kulterer, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 6, 2018
Cell-Free Plasma DNA-Guided Treatment With Osimertinib in Patients With Advanced EGFR-Mutated NSCLCAnna Buder, Maximilian J Hochmair, Sophia Schwab, et al.
Insights Into Imaging|March 16, 2026
CT acquisition protocols in lung cancer screening: implications for guideline development from a worldwide surveyMathis Franz Georg Konrad, Emily Nischwitz, Joanna Chorostowska-Wynimko, et al.
Wiener Klinische Wochenschrift|February 4, 2026
[Evaluation and clinical management of interstitial lung abnormalities : Position paper of the Austrian Society of Pneumology (ÖGP) and the Austrian Radiological Society (ÖRG) 2026]Tjaša Kamenski-Rathmanner, Georg Sterniste, David Lang, et al.
Insights Into Imaging|October 22, 2024
Strengthening lung cancer screening in Europe: fostering participation, improving outcomes, and addressing health inequalities through collaborative initiatives in the SOLACE consortiumHans-Ulrich Kauczor, Oyunbileg von Stackelberg, Emily Nischwitz, et al.
European Radiology|May 9, 2024
Ultra-low-dose vs. standard-of-care-dose CT of the chest in patients with post-COVID-19 conditions-a prospective intra-patient multi-reader studyChristian Wassipaul, Daria Kifjak, Ruxandra-Iulia Milos, et al.
Pharmaceuticals (Basel, Switzerland)|November 11, 2020
Later-Line Treatment with Lorlatinib in <i>ALK</i>- and <i>ROS1</i>-Rearrangement-Positive NSCLC: A Retrospective, Multicenter AnalysisMaximilian J Hochmair, Hannah Fabikan, Oliver Illini, et al.
Pageof 23

Showing results (171-180 of 230) with videos related to

Sort By:
Pageof 23
Radiology|March 25, 2017
Lung-RADS Category 4X: Does It Improve Prediction of Malignancy in Subsolid Nodules?Kaman Chung, Colin Jacobs, Ernst T Scholten, et al.
European Journal of Radiology|July 18, 2016
Antisynthetase syndrome: Pulmonary computed tomography findings of adult patients with antibodies to aminoacyl-tRNA synthetasesYuko Waseda, Takeshi Johkoh, Ryoko Egashira, et al.
The Journal of Thoracic and Cardiovascular Surgery|April 15, 2018
Intraoperative extracorporeal membrane oxygenation and the possibility of postoperative prolongation improve survival in bilateral lung transplantationKonrad Hoetzenecker, Stefan Schwarz, Moritz Muckenhuber, et al.
Journal of Autoimmunity|August 8, 2025
FAPI PET/CT for tracking disease trajectory in myositis-related interstitial lung diseaseKastriot Kastrati, Svitlana Pochepnia, Oana C Kulterer, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|March 6, 2018
Cell-Free Plasma DNA-Guided Treatment With Osimertinib in Patients With Advanced EGFR-Mutated NSCLCAnna Buder, Maximilian J Hochmair, Sophia Schwab, et al.
Insights Into Imaging|March 16, 2026
CT acquisition protocols in lung cancer screening: implications for guideline development from a worldwide surveyMathis Franz Georg Konrad, Emily Nischwitz, Joanna Chorostowska-Wynimko, et al.
Wiener Klinische Wochenschrift|February 4, 2026
[Evaluation and clinical management of interstitial lung abnormalities : Position paper of the Austrian Society of Pneumology (ÖGP) and the Austrian Radiological Society (ÖRG) 2026]Tjaša Kamenski-Rathmanner, Georg Sterniste, David Lang, et al.
Insights Into Imaging|October 22, 2024
Strengthening lung cancer screening in Europe: fostering participation, improving outcomes, and addressing health inequalities through collaborative initiatives in the SOLACE consortiumHans-Ulrich Kauczor, Oyunbileg von Stackelberg, Emily Nischwitz, et al.
European Radiology|May 9, 2024
Ultra-low-dose vs. standard-of-care-dose CT of the chest in patients with post-COVID-19 conditions-a prospective intra-patient multi-reader studyChristian Wassipaul, Daria Kifjak, Ruxandra-Iulia Milos, et al.
Pharmaceuticals (Basel, Switzerland)|November 11, 2020
Later-Line Treatment with Lorlatinib in <i>ALK</i>- and <i>ROS1</i>-Rearrangement-Positive NSCLC: A Retrospective, Multicenter AnalysisMaximilian J Hochmair, Hannah Fabikan, Oliver Illini, et al.
Pageof 23